Michael J. La Barre Halozyme Therapeutics, Inc. (HALO) insider trading activity

Michael J. La Barre is SVP, CHIEF TECHNICAL OFFICER of HALOZYME THERAPEUTICS, INC.. Currently has a direct ownership of 173,756 shares of HALO, which is worth approximately $10.3 Million. The most recent transaction as insider was on Aug 22, 2023, when has been sold 10,000 shares (Common Stock) at a price of $42.41 per share, resulting in proceeds of $424,099. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 174K

3.32% 3M change

14.38% 12M change

Total Value Held $10.3 Million

Michael J. LaBarre Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 22 2023	SELL Open market or private sale	$424,099 $42.41 p/Share	10,000 Reduced 6.18%	151,911 Common Stock
Aug 22 2023	BUY Exercise of conversion of derivative security	$192,000 $19.2 p/Share	10,000 Added 5.88%	159,986 Common Stock
Jul 18 2023	SELL Open market or private sale	$404,300 $40.43 p/Share	10,000 Reduced 6.58%	141,911 Common Stock
Jul 18 2023	BUY Exercise of conversion of derivative security	$268,800 $13.44 p/Share	20,000 Added 11.63%	151,911 Common Stock
Jun 21 2023	SELL Open market or private sale	$360,000 $36.0 p/Share	10,000 Reduced 6.58%	141,911 Common Stock
Jun 21 2023	BUY Exercise of conversion of derivative security	$184,100 $18.41 p/Share	10,000 Added 6.18%	151,911 Common Stock
Apr 18 2023	SELL Open market or private sale	$360,000 $36.0 p/Share	10,000 Reduced 6.58%	141,911 Common Stock
Apr 18 2023	BUY Exercise of conversion of derivative security	$184,100 $18.41 p/Share	10,000 Added 6.18%	151,911 Common Stock
Feb 27 2023	SELL Open market or private sale	$495,500 $49.55 p/Share	10,000 Reduced 6.71%	138,927 Common Stock
Feb 16 2023	SELL Open market or private sale	$141,770 $49.26 p/Share	2,878 Reduced 1.9%	148,927 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	-	6,112 Added 3.87%	151,805 Common Stock
Feb 15 2023	SELL Open market or private sale	$483,900 $48.39 p/Share	10,000 Reduced 6.52%	143,477 Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$57,564 $49.2 p/Share	1,170 Reduced 0.8%	145,693 Common Stock
Feb 15 2023	BUY Exercise of conversion of derivative security	-	3,386 Added 2.25%	146,863 Common Stock
Feb 12 2023	SELL Payment of exercise price or tax liability	$133,307 $48.92 p/Share	2,725 Reduced 1.74%	153,477 Common Stock
Feb 12 2023	BUY Exercise of conversion of derivative security	-	7,883 Added 4.8%	156,202 Common Stock
Feb 10 2023	SELL Payment of exercise price or tax liability	$144,362 $48.92 p/Share	2,951 Reduced 1.95%	148,319 Common Stock
Feb 10 2023	BUY Exercise of conversion of derivative security	-	8,133 Added 5.1%	151,270 Common Stock
Jan 17 2023	SELL Open market or private sale	$506,700 $50.67 p/Share	10,000 Reduced 6.53%	143,137 Common Stock
Dec 13 2022	SELL Open market or private sale	$586,600 $58.66 p/Share	10,000 Reduced 6.13%	153,137 Common Stock
Nov 15 2022	SELL Open market or private sale	$542,900 $54.29 p/Share	10,000 Reduced 5.78%	163,137 Common Stock
Feb 15 2022	SELL Payment of exercise price or tax liability	$40,283 $34.43 p/Share	1,170 Reduced 0.67%	173,137 Common Stock
Feb 15 2022	BUY Exercise of conversion of derivative security	-	3,386 Added 1.91%	174,307 Common Stock
Feb 14 2022	SELL Payment of exercise price or tax liability	$67,112 $33.64 p/Share	1,995 Reduced 1.15%	170,921 Common Stock
Feb 14 2022	BUY Exercise of conversion of derivative security	-	5,771 Added 3.23%	172,916 Common Stock

MJL

Michael J. La Barre

SVP, CHIEF TECHNICAL OFFICER

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HALO shares.

Notify only if

Value

Insider Trading

Get notified when an Halozyme Therapeutics, Inc. insider buys or sells HALO shares.

Notify only if

Operation

Value

Type

News

Receive news related to HALOZYME THERAPEUTICS, INC.

Track Activities on HALO

Account